The prevalence of attention-deficit/hyperactivity disorder (ADHD) diagnoses in the United States increased significantly from 1997 to 2016, reports a new study.
Parent behavior training interventions are more effective than medication at treating attention-deficit hyperactivity disorder, according to a literature review in the online April 1 Pediatrics.
For nearly 30% of children with attention-deficit hyperactivity disorder (ADHD), the disorder lasts into adulthood. These children are also more at risk for other psychiatric disorders as adults, researchers reported in the online March 4 Pediatrics.
Five major psychiatric disorders—autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia—share underlying genetic variants, according to the results of a genome-wide analysis published in the online February 28 Lancet.
According to Teva Pharmaceutical Industries, Ltd., the FDA has announced approval of the generic version of Adderall XR®, a popular drug for the treatment of attention-deficit/hyperactivity disorder (ADHD).
The overall number of emergency department (ED) visits involving attention deficit/hyperactivity disorder (ADHD) medications more than doubled between 2005 and 2010, going from 13,379 visits to 31,244 visits, according to a report by the Substance Abuse Mental Health Services Administration (SAMHSA).